Kothari G, O'Byrne KJ, Brown C, Stockler MR, et al. A Randomized Phase 2 Trial of Nivolumab and Stereotactic Ablative Body Radiotherapy (SABR) in Advanced Non-Small Cell Lung Cancer, Progressing After First- or Second-Line Chemotherapy (NIVORAD). Int J Radiat Oncol Biol Phys 2025 Dec 19:S0360-3016(25)06610.
PMID: 41422917